SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:146253234"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:146253234" > Temporal trends in ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Uijl, A (author)

Temporal trends in heart failure medication prescription in a population-based cohort study

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021-03-02
  • BMJ,2021

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:146253234
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:146253234URI
  • https://doi.org/10.1136/bmjopen-2020-043290DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • We examined temporal heart failure (HF) prescription patterns in a large representative sample of real-world patients in the UK, using electronic health records (EHR).MethodsFrom primary and secondary care EHR, we identified 85 732 patients with a HF diagnosis between 2002 and 2015. Almost 50% of patients with HF were women and the median age was 79.1 (IQR 70.2–85.7) years, with age at diagnosis increasing over time.ResultsWe found several trends in pharmacological HF management, including increased beta blocker prescriptions over time (29% in 2002–2005 and 54% in 2013–2015), which was not observed for mineralocorticoid receptor-antagonists (MR-antagonists) (18% in 2002–2005 and 18% in 2013–2015); higher prescription rates of loop diuretics in women and elderly patients together with lower prescription rates of angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers, beta blockers or MR-antagonists in these patients; little change in medication prescription rates occurred after 6 months of HF diagnosis and, finally, patients hospitalised for HF who had no recorded follow-up in primary care had considerably lower prescription rates compared with patients with a HF diagnosis in primary care with or without HF hospitalisation.ConclusionIn the general population, the use of MR-antagonists for HF remained low and did not change throughout 13 years of follow-up. For most patients, few changes were seen in pharmacological management of HF in the 6 months following diagnosis.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Vaartjes, I (author)
  • Denaxas, S (author)
  • Hemingway, H (author)
  • Shah, A (author)
  • Cleland, J (author)
  • Grobbee, D (author)
  • Hoes, A (author)
  • Asselbergs, FW (author)
  • Koudstaal, S (author)

Related titles

  • In:BMJ open: BMJ11:3, s. e043290-2044-6055

Internet link

Find in a library

  • BMJ open (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view